A Safety and Efficacy Trial of TTHX1114 in People With CED

NCT04812067 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Corneal Endothelial Dystrophy

Interventions

DRUG: TTHX1114

Sponsor

Trefoil Therapeutics, Inc.